Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.

AIMS On the basis of the evidence from autopsy studies, it is accepted that compensatory enlargement (remodelling) of coronary arteries during progression of atherosclerosis diminishes once atheroma burden (cross-sectional area stenosis) reaches approximately 40%. Our aim was to evaluate whether atheroma burden is a limiting factor for coronary arterial remodelling using in vivo serial intravascular ultrasound (IVUS). METHODS AND RESULTS From the cohort of the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial, we identified 210 focal coronary lesions at baseline IVUS. Of these, 128 lesions that had an increase in atheroma area at the 18-month follow-up IVUS were included in the analysis. Lesions were matched at baseline and follow-up. The increase in external elastic membrane (EEM) area for each mm(2) increase in atheroma area was not significantly different in lesions with <40 and >or=40% atheroma burden at baseline (1.62 vs. 1.28 mm(2), P=0.30). There were no correlations between atheroma burden at baseline and change in EEM (r=0.02, P=0.86) or change in lumen (r=0.04, P=0.64) areas. CONCLUSION Assessment of coronary arterial remodelling by serial IVUS revealed that compensatory remodelling is not limited by atheroma burden. Atheroma burden is not a determinant of arterial enlargement during the progression of atherosclerosis.

[1]  Raimund Erbel,et al.  Spectrum of remodeling behavior observed with serial long-term (>/=12 months) follow-up intravascular ultrasound studies in left main coronary arteries. , 2004, The American journal of cardiology.

[2]  M. Leon,et al.  Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease. , 1999, The American journal of cardiology.

[3]  W. Bocksch,et al.  Effects of lipid-lowering therapy on coronary artery remodeling , 2004, Coronary artery disease.

[4]  Renu Virmani,et al.  Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis , 2002, Circulation.

[5]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[6]  E. Tuzcu,et al.  Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease , 2005 .

[7]  R. Virmani,et al.  Arterial remodeling in the left coronary system: the role of high-density lipoprotein cholesterol. , 1999, Journal of the American College of Cardiology.

[8]  A. Yeung,et al.  Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study. , 1997, Circulation.

[9]  A. van der Lugt,et al.  Remodeling of atherosclerotic coronary arteries assessed with intravascular ultrasound in vitro. , 1997, The American journal of cardiology.

[10]  T M Morgan,et al.  Remodeling of coronary arteries in human and nonhuman primates. , 1994, JAMA.

[11]  Antonio Colombo,et al.  Clinical application and image interpretation in intracoronary ultrasound , 1998 .

[12]  Bruce R. Brodie,et al.  Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis A Randomized Controlled Trial , 2004 .

[13]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[14]  M. Fishbein,et al.  Regional remodeling of atherosclerotic arteries: a major determinant of clinical manifestations of disease. , 1997, Journal of the American College of Cardiology.

[15]  I. Palacios,et al.  Development of coronary compensatory enlargement in vivo: sequential assessments with intravascular ultrasound. , 1995, American heart journal.

[16]  B Hillen,et al.  Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. , 1998, Journal of the American College of Cardiology.

[17]  J. Hermiller,et al.  In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. , 1993, The American journal of cardiology.

[18]  J. Zamorano,et al.  Coronary artery remodeling in atherosclerotic disease: An intravascular ultrasonic study in vivo , 1993, Coronary artery disease.

[19]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[20]  J. Isner,et al.  Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. , 1994, Circulation.

[21]  S. Higano,et al.  Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. , 2000, Arteriosclerosis, thrombosis, and vascular biology.